ADMA BIOLOGICS, INC. Shares Outstanding (Cover Page)
ADMA BIOLOGICS, INC. (ADMA) had Shares Outstanding (Cover Page) of 223.98 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 223.98M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 231.77M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 238.16M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 238.00M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 223.98M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 231.77M shares 10-Q · filed 2026-05-06 |
| 2026-02-20 | 238.16M shares 10-K · filed 2026-02-25 |
| 2025-11-03 | 238.00M shares 10-Q · filed 2025-11-05 |
| 2025-08-01 | 238.63M shares 10-Q · filed 2025-08-06 |
| 2025-05-02 | 238.73M shares 10-Q · filed 2025-05-07 |
| 2025-03-10 | 237.62M shares 10-K · filed 2025-03-18 |
| 2024-11-01 | 236.39M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 233.08M shares 10-Q · filed 2024-08-08 |
| 2024-05-03 | 231.81M shares 10-Q · filed 2024-05-09 |
| 2024-02-23 | 228.22M shares 10-K · filed 2024-02-28 |
| 2023-11-03 | 225.97M shares 10-Q · filed 2023-11-08 |
| 2023-08-04 | 224.91M shares 10-Q · filed 2023-08-09 |
| 2023-05-05 | 222.27M shares 10-Q · filed 2023-05-10 |
| 2023-03-17 | 222.16M shares 10-K · filed 2023-03-23 |
| 2022-11-04 | 196.78M shares 10-Q · filed 2022-11-09 |
| 2022-08-05 | 196.36M shares 10-Q · filed 2022-08-10 |
| 2022-05-06 | 196.35M shares 10-Q · filed 2022-05-11 |
| 2022-03-18 | 195.92M shares 10-K · filed 2022-03-24 |
| 2021-11-05 | 195.81M shares 10-Q · filed 2021-11-10 |
| 2021-08-06 | 132.77M shares 10-Q · filed 2021-08-11 |
| 2021-05-07 | 128.19M shares 10-Q · filed 2021-05-12 |
| 2021-03-16 | 121.28M shares 10-K · filed 2021-03-25 |
| 2020-11-02 | 94.55M shares 10-Q · filed 2020-11-05 |
| 2020-08-03 | 86.35M shares 10-Q · filed 2020-08-05 |
| 2020-05-04 | 86.35M shares 10-Q · filed 2020-05-06 |
| 2020-03-10 | 86.35M shares 10-K · filed 2020-03-13 |
| 2019-11-01 | 59.32M shares 10-Q · filed 2019-11-06 |
| 2019-08-06 | 59.32M shares 10-Q · filed 2019-08-08 |
| 2019-05-07 | 46.38M shares 10-Q · filed 2019-05-08 |
| 2019-03-11 | 46.35M shares 10-K · filed 2019-03-13 |
| 2018-11-05 | 46.35M shares 10-Q · filed 2018-11-09 |
| 2018-08-10 | 46.35M shares 10-Q · filed 2018-08-10 |
| 2018-05-14 | 36.73M shares 10-Q · filed 2018-05-14 |
| 2018-03-09 | 45.32M shares 10-K · filed 2018-03-29 |
| 2017-11-01 | 25.79M shares 10-Q · filed 2017-11-03 |
| 2017-08-11 | 25.79M shares 10-Q · filed 2017-08-11 |
| 2017-05-12 | 12.89M shares 10-Q · filed 2017-05-12 |
| 2017-02-24 | 12.89M shares 10-K · filed 2017-02-24 |
| 2016-11-10 | 12.89M shares 10-Q · filed 2016-11-10 |
| 2016-08-12 | 12.89M shares 10-Q · filed 2016-08-12 |
| 2016-05-13 | 12.89M shares 10-Q · filed 2016-05-13 |
| 2016-03-23 | 10.71M shares 10-K · filed 2016-03-23 |
| 2015-11-10 | 10.71M shares 10-Q · filed 2015-11-10 |
| 2015-08-10 | 10.71M shares 10-Q · filed 2015-08-11 |
| 2015-05-12 | 10.71M shares 10-Q · filed 2015-05-12 |
| 2015-03-06 | 9.29M shares 10-K · filed 2015-03-09 |
| 2014-11-07 | 9.29M shares 10-Q · filed 2014-11-10 |
| 2014-08-11 | 9.29M shares 10-Q · filed 2014-08-11 |
| 2014-05-09 | 9.29M shares 10-Q · filed 2014-05-12 |
| 2014-03-28 | 9.29M shares 10-K · filed 2014-03-28 |
| 2013-11-12 | 9.22M shares 10-Q · filed 2013-11-12 |
| 2013-08-12 | 5.87M shares 10-Q · filed 2013-08-12 |
| 2013-05-13 | 5.87M shares 10-Q · filed 2013-05-14 |
| 2013-03-05 | 4.62M shares 10-K · filed 2013-03-06 |
| 2012-11-12 | 4.62M shares 10-Q · filed 2012-11-13 |
| 2012-08-13 | 4.65M shares 10-Q · filed 2012-08-14 |
| 2012-05-14 | 4.65M shares 10-Q · filed 2012-05-15 |
| 2012-01-31 | 2.50M shares 10-Q · filed 2012-02-01 |
| 2011-10-28 | 2.50M shares 10-Q · filed 2011-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |